Chennai: Chennai-based EID Parry India, a Murugappa Group company, today informed BSE that it has acquired 48 per cent stake in a US-based nutraceutical company Valensa International to expand its business.

Also Read   News Now Paper Specials - Sensex slumps 749pts on Satyam fiasco - Sun Pharma gets USFDA nod for four generic drugs - Sebi orders probe into Satyam case - No significant business exposure to Satyam: banks - IIFCL to provide Rs 1,00,000 cr of low-cost funds - Satyam loses Rs 10K cr in m-cap More     Also Read   News Now Paper Specials - More lending rate cuts in Feb - Taro challenges Sun Pharma to shareholder referendum - DoT offers compromise on auctions of 3G spectrum - Government to fast-track insurance Bills in Parliament - Making the web talk on cellphones More   Also Read   News Now Paper Specials   - US Election: Obama elected 44th US President - Q2 FY09 Results: Earnings season - Subprime Crisis: US faces economic turmoil - Fighting Inflation : Inflation at a 13-year high - Your Money : Personal finance - Credit Policy : RBI's monetary policy review  More

The company did not disclose the deal amount. In a statement to the BSE, the company said the new venture will help EID to expand its footprints in the nutraceutical space and help the US company with manufacturing and research facilities.

The Indian company also announced about its plan to set up a life sciences division at the IIT Madras Technology Park for developing novel formulations to address various lifestyle diseases.

EID Parry is a leading manufacturer and exporter of certified Spirulina and carotenoids such as natural beta cartoene, astaxanthin and tomato lycopene.

Read Business news in    Get Home Loan Counselling From HDFC - click here to know more.   India's premier online business magazine   Free E-book on The Future of Business Intelligence Advt